Vishwakarma P, Shankar K, Joy I, Varma TR. To compare the effectiveness of recombinant gonadotropin versus the combination of recombinant follicle stimulating hormone and highly purified human menopausal gonadotropin versus urinary human menopausal gonadotropin alone for ovarian stimulation in women undergoing in vitro fertilisation or intracytoplasmic sperm injection treatment cycles. Int J Reprod Contracept Obstet Gynecol [Internet]. 2017 Jan. 5 [cited 2025 Dec. 4];5(6):1827-31. Available from: https://www.ijrcog.org/index.php/ijrcog/article/view/1218